BioSig Technologies, Inc. STEX Derivative Assets Liabilities At Fair Value Net
Derivative Assets Liabilities At Fair Value Net at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s derivative assets liabilities at fair value net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s derivative assets liabilities at fair value net?
- BioSig Technologies, Inc. (STEX) reported derivative assets liabilities at fair value net of $389.7M in Q4 2025.
- What does derivative assets liabilities at fair value net mean?
- The net position of derivative financial instruments held by the company, reflecting the difference between derivative assets and liabilities at fair value. It indicates the company's exposure to market volatility and the effectiveness of its hedging strategies for commodities.